- Global Pharma News & Resources

Global Preclinical Imaging Market Report – insightSLICE

The Global Preclinical Imaging market size was estimated to be US$ 3.3 billion in 2021 and is expected grow at a CAGR of 3% between 2023 to 2032. Animal model research with minimal or non-invasive, in vivo imaging processes, is predominantly used.

Preclinical imaging refers to the visualization of tissue, cells, or biochemical interactions within a living organism with the use of in vivo imaging methods.

Reduced invasive methods, less biological variability, and a small number of animals or samples are required to generate good results using preclinical imaging tools. Spatiotemporal distribution of processes, in vivo characterization along with living tracking and diagnosis, is done easily because of such advanced preclinical imaging tools.

Drug delivery systems and efficacy studies are also successfully done by the use of several preclinical imaging apparatuses.

In recent years large companies have been utilizing small-animal imaging techniques to understand the complications and significance of their products before clinical trials. This process is also outsourced to an increasing number of clinical research organizations (CRO) which is enabling the preclinical imaging market.

Along with an overall growth in pharmaceutical research output rising sales of preclinical imaging devices and tools are taking place.

Access the sample report:

Driving factors for the growth of Global Preclinical Imaging Market

The global preclinical imaging market is primarily growing due to increased investment/ funding by corporations and governments. Constant technological developments in the preclinical imaging sector are changing the outlook of researchers regarding traditional methods.

This rising demand for non-invasive techniques is also expected to drive the growth of the preclinical imaging market.

Veterinary hospitals and educational institutes that undertake small-scale research and diagnostics also provide certain contributions to the growth of this sector.

Read our global preclinical market report that has been generated through extensive research to understand the preclinical imaging market conditions for the next decade.

The increased restriction and enforcement of regulations placed on animal testing are impeding the adoption of preclinical imaging tools to a certain extent. In vitro research, small dose studies, and computational research including virtual drug testing are limiting the sales prospects for preclinical imaging markets.

Non-invasive imaging techniques like MRI and CT scans are enabling positive growth and may overcome the financial stagnation of the above-said limitations.

The Covid-19 pandemic also caused a dampening effect on the growth of the preclinical imaging market. Delayed production, delivery, and shortages of raw products caused by lockdown measures were important limiting factors.

However, the preclinical imaging market is returning to normalcy quicker and may gain significant ground in the coming years.

Read more about the report inclusions:

The leading market segments of Global Preclinical Imaging Market

Newer methods and tools are widening the scope of preclinical imaging tools in diagnosis and detection. Cancer research makes significant use of preclinical imaging tools for research.

Devices with higher sensitivity along with the use of digital technologies will enable a substantial impact in cardiology, obstetrics, and gynecology research. New techniques like micro-CT and micro-MRI combined with functional experimentation such as micro-PET are also enabling the domains of research and increasing the size of the preclinical imaging market.

Currently, optical imaging tools are dominant due to their widespread use in small-animal imaging and drug development and therefore garnering the highest revenue in this sector.

Having said that, multimodal imaging devices are expected to see higher growth rates in the future. Integrated digital imaging systems are better suited for molecular and anatomical studies and the development of such tools and devices will boost new product catalogues and the overall growth of the global preclinical research market.

Because the reagents are frequently used, and their routine replenishments are required, they account for a significant share of revenue in the preclinical imaging market.

The biggest types of reagents are Fluorescent and bioluminescent reagents, preclinical nuclear imaging chemicals, and preclinical PET tracers and they are all expected to rise as market demand for preclinical imaging grows.

Related reports:

Global Drug Delivery Devices Market:

Global Positron Emission Tomography (PET) Systems Market:

North America has the highest sales and revenue growth observed for the global preclinical imaging market. The adoption of preclinical imaging tools is done by a large number of preclinical research projects, high-quality research infrastructure, and the availability of skilled human resources.

This is driving the rise of the preclinical imaging market across this region. Government initiatives along with a rise in funding regimes are enabling more clinical R&D projects, especially throughout the USA and Canada. Due to several such reasons, North America is expected to maintain its lead and grow within the preclinical imaging market significantly.

The Asia Pacific region is expected to demonstrate a high growth rate for the preclinical imaging market. Low wages, relaxed mandatory regulations, and vast amounts of skilled labor are enhancing the uptake of preclinical R&D along with market growth for the preclinical imaging market for the studied timeframe.

As a result, clinical research outsourcing is a booming industry in India and China which will see a large boom for preclinical tools in these countries as well.

The key players of the Global Preclinical Imaging Market are:

Acquisitions, portfolio diversification, and regional expansion will also boost corporate investment in the preclinical imaging markets supporting the growth forecast. Initiatives like collaborations and outsourcing are also creating better opportunities in preclinical imaging markets.

Agilent Technologies, Bruker Corporation, Mediso Ltd., MILabs B.V., MR Solutions, Molecubes, General Electric (GE), PerkinElmer, Inc., Siemens A.G., TriFoil Imaging, VisualSonics Inc. (Fujifilm) are leading the market of preclinical imaging products and technology.

Proceed to purchase:

Global Preclinical Imaging Market Key Segments:

Based on Product 

  • CT Imaging
  • MRI Imaging
  • PET/SPECT Imaging
  • Multi-modal Imaging
  • Optical Imaging
  • Ultrasound Imaging
  • Photoacoustic Imaging
  • Reagents
  • Other Services

Based on Specialization 

  • Research and Development
  • Drug Discovery

Based on End User 

  • Biotech Companies
  • Pharmaceutical companies
  • Research institutes

Based on Geography

  • North America
    • United States
    • Canada
    • Rest of North America
  • Europe
    • Germany
    • United Kingdom
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • India
    • China
    • Australia
    • Rest of Asia Pacific
  • Middle East & Africa
    • UAE
    • Saudi Arabia
    • South Africa
    • Rest of the Middle East & Africa
  • South America
    • Brazil
    • Rest of South America

insightSLICE is a market intelligence and strategy consulting company. The company provides tailor-made and off the shelf market research studies. The prime focus of the company is on strategy consulting to provide end-to-end solutions. For more details, please contact our research and consulting team at

Contact us:

Alex R

+1 707 736 6633

Linkedin | Twitter

Editor Details

Last Updated: 08-Nov-2022